RxDoctor Payments Data

Khanh Nguyen, PA

Physician Assistant · San Diego, CANPI 1427312644

Payments from drug & device makers

$695in general payments, 2019–2025

Across 15 payments — averaging $46.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$393
  • Gilead$96
  • Sumitomo Pharma America, Inc.$64
  • AbbVie$60
  • 180 Medical, Inc.$29
  • Johnson & Johnson$22
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$30243%
  • Education$39357%

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$695 in reported general payments places this provider in the 65th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$36,922
Medicare patients
210
Services billed
481

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron33$30,496
GemtesaVibegron34$26,346
EstringEstradiol19$10,094
Estradiol88$6,585
YuvafemEstradiol13$1,777
Methenamine Hippurate12$1,686
Trospium Chloride16$1,035
Metronidazole15$626
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst45$519
Cephalexin14$58
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$57

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$393$30,49633 claims
Sumitomo Pharma America, Inc.Gemtesa$64$26,34634 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 10,423 physician assistant providers in California.

Other physician assistant in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →